BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9950685)

  • 1. Novel regulation of type IV collagenase (matrix metalloproteinase-9 and -2) activities by transforming growth factor-beta1 in human prostate cancer cell lines.
    Sehgal I; Thompson TC
    Mol Biol Cell; 1999 Feb; 10(2):407-16. PubMed ID: 9950685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
    Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
    J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor beta1 stimulates contrasting responses in metastatic versus primary mouse prostate cancer-derived cell lines in vitro.
    Sehgal I; Baley PA; Thompson TC
    Cancer Res; 1996 Jul; 56(14):3359-65. PubMed ID: 8764134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of matrix metalloproteinases and their inhibitors in human glomerular epithelial cells in vitro.
    Martin J; Steadman R; Knowlden J; Williams J; Davies M
    J Am Soc Nephrol; 1998 Sep; 9(9):1629-37. PubMed ID: 9727371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression.
    Overall CM; Wrana JL; Sodek J
    J Biol Chem; 1991 Jul; 266(21):14064-71. PubMed ID: 1649834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of human mesangial cell collagen expression by transforming growth factor-beta1.
    Poncelet AC; Schnaper HW
    Am J Physiol; 1998 Sep; 275(3):F458-66. PubMed ID: 9729521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter.
    Bian J; Sun Y
    Mol Cell Biol; 1997 Nov; 17(11):6330-8. PubMed ID: 9343394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
    Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
    J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of transforming growth factor beta 1 on the expression of genes coding for matrix metalloproteinases and tissue inhibitors of metalloproteinases during regeneration from cerulein-induced pancreatitis.
    Müller-Pillasch F; Gress TM; Yamaguchi H; Geng M; Adler G; Menke A
    Pancreas; 1997 Aug; 15(2):168-75. PubMed ID: 9260202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes.
    Mäkelä M; Larjava H; Pirilä E; Maisi P; Salo T; Sorsa T; Uitto VJ
    Exp Cell Res; 1999 Aug; 251(1):67-78. PubMed ID: 10438572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver.
    Milani S; Herbst H; Schuppan D; Grappone C; Pellegrini G; Pinzani M; Casini A; Calabró A; Ciancio G; Stefanini F
    Am J Pathol; 1994 Mar; 144(3):528-37. PubMed ID: 8129038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro expression of MMP-2 and MMP-9 in glioma cells following exposure to inflammatory mediators.
    Esteve PO; Tremblay P; Houde M; St-Pierre Y; Mandeville R
    Biochim Biophys Acta; 1998 May; 1403(1):85-96. PubMed ID: 9622599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory mechanisms for the expression of type IV collagenases/gelatinases in murine macrophages.
    Xie B; Dong Z; Fidler IJ
    J Immunol; 1994 Apr; 152(7):3637-44. PubMed ID: 8144939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP).
    Sato H; Takino T; Kinoshita T; Imai K; Okada Y; Stetler Stevenson WG; Seiki M
    FEBS Lett; 1996 May; 385(3):238-40. PubMed ID: 8647259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel organ culture method to study the function of human odontoblasts in vitro: gelatinase expression by odontoblasts is differentially regulated by TGF-beta1.
    Tjäderhane L; Salo T; Larjava H; Larmas M; Overall CM
    J Dent Res; 1998 Jul; 77(7):1486-96. PubMed ID: 9663433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bombesin-dependent pro-MMP-9 activation in prostatic cancer cells requires beta1 integrin engagement.
    Festuccia C; Angelucci A; Gravina G; Eleuterio E; Vicentini C; Bologna M
    Exp Cell Res; 2002 Oct; 280(1):1-11. PubMed ID: 12372334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of collagen degradation in the rat myocardium after infarction.
    Cleutjens JP; Kandala JC; Guarda E; Guntaka RV; Weber KT
    J Mol Cell Cardiol; 1995 Jun; 27(6):1281-92. PubMed ID: 8531210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells.
    Yu M; Sato H; Seiki M; Thompson EW
    Cancer Res; 1995 Aug; 55(15):3272-7. PubMed ID: 7614461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas.
    Kossakowska AE; Edwards DR; Prusinkiewicz C; Zhang MC; Guo D; Urbanski SJ; Grogan T; Marquez LA; Janowska-Wieczorek A
    Blood; 1999 Sep; 94(6):2080-9. PubMed ID: 10477738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of mycosis fungoides is associated with changes in angiogenesis and expression of the matrix metalloproteinases 2 and 9.
    Vacca A; Moretti S; Ribatti D; Pellegrino A; Pimpinelli N; Bianchi B; Bonifazi E; Ria R; Serio G; Dammacco F
    Eur J Cancer; 1997 Sep; 33(10):1685-92. PubMed ID: 9389934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.